A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Clinical trial NCT01474239 · COMPLETED

Trial details

NCT number: NCT01474239
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2011-11-01
Primary completion: 2013-12-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.